{"id":58518,"date":"2026-03-02T13:12:46","date_gmt":"2026-03-02T05:12:46","guid":{"rendered":"https:\/\/flcube.com\/?p=58518"},"modified":"2026-03-02T13:12:47","modified_gmt":"2026-03-02T05:12:47","slug":"china-sco-metabolic-disease-cooperation-center-established-at-ruijin-hospital-first-national-level-sco-platform-in-shanghai","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=58518","title":{"rendered":"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai"},"content":{"rendered":"\n<p>The <strong>China\u2011Shanghai Cooperation Organization (SCO) Metabolic Disease Cooperation Center<\/strong> was officially established at <strong>Ruijin Hospital<\/strong>, affiliated with <strong>Shanghai Jiao Tong University School of Medicine<\/strong>. This marks the <strong>first national\u2011level SCO specialized cooperation platform hosted by Shanghai<\/strong>, representing a significant advancement in China&#8217;s efforts to drive <strong>global prevention and control of metabolic diseases<\/strong> through regional multilateral collaboration.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-institutional-milestone\">Institutional Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Center Name<\/strong><\/td><td>China\u2011SCO Metabolic Disease Cooperation Center<\/td><\/tr><tr><td><strong>Host Institution<\/strong><\/td><td>Ruijin Hospital, Shanghai Jiao Tong University School of Medicine<\/td><\/tr><tr><td><strong>Establishment Date<\/strong><\/td><td>27\u202fFeb\u202f2026<\/td><\/tr><tr><td><strong>Significance<\/strong><\/td><td>First national\u2011level SCO specialized cooperation platform in Shanghai<\/td><\/tr><tr><td><strong>Geographic Scope<\/strong><\/td><td>Shanghai Cooperation Organization member states<\/td><\/tr><tr><td><strong>Strategic Goal<\/strong><\/td><td>Advance global metabolic disease prevention and control<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-core-mission\">Core Mission<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Objective<\/th><th>Description<\/th><\/tr><\/thead><tbody><tr><td><strong>Regional Coordination<\/strong><\/td><td>Promote expertise sharing across SCO member states<\/td><\/tr><tr><td><strong>Technology Scaling<\/strong><\/td><td>Drive technological iteration and scalable solutions<\/td><\/tr><tr><td><strong>Governance Innovation<\/strong><\/td><td>Foster sustainable development through innovative mechanisms<\/td><\/tr><tr><td><strong>Model Globalization<\/strong><\/td><td>Advance international adoption of the &#8220;SCO Demonstration&#8221; approach<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-four-strategic-pillars\">Four Strategic Pillars<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Pillar<\/th><th>Function<\/th><\/tr><\/thead><tbody><tr><td><strong>1. International Medical Service Hub<\/strong><\/td><td>Deliver cross\u2011border clinical services and telemedicine<\/td><\/tr><tr><td><strong>2. Dual\u2011Track Precision Talent Training Base<\/strong><\/td><td>Develop specialized healthcare professionals through academic and vocational pathways<\/td><\/tr><tr><td><strong>3. Regional Disease Strategic Research Base<\/strong><\/td><td>Conduct epidemiological and translational research on metabolic diseases<\/td><\/tr><tr><td><strong>4. Regional Pharmaceutical and Medical Technology Cooperation Base<\/strong><\/td><td>Facilitate joint R&amp;D, technology transfer, and regulatory harmonization<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Diplomatic Health Initiative:<\/strong> The center exemplifies <strong>China&#8217;s health diplomacy<\/strong> through the SCO framework, leveraging medical expertise as soft power to strengthen regional ties.<\/li>\n\n\n\n<li><strong>Metabolic Disease Burden:<\/strong> SCO member states\u2014including China, Russia, India, Pakistan, and Central Asian nations\u2014face <strong>rising diabetes and obesity prevalence<\/strong>; coordinated response addresses shared public health challenges.<\/li>\n\n\n\n<li><strong>Shanghai Healthcare Leadership:<\/strong> Ruijin Hospital&#8217;s selection as host reinforces Shanghai&#8217;s position as <strong>China&#8217;s premier medical hub<\/strong> and gateway for international health collaboration.<\/li>\n\n\n\n<li><strong>Technology Export Platform:<\/strong> The &#8220;SCO Demonstration&#8221; model enables <strong>scalable deployment<\/strong> of China&#8217;s digital health, AI diagnostics, and precision medicine innovations across diverse healthcare systems.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context\">Market Context<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Factor<\/th><th>Impact<\/th><\/tr><\/thead><tbody><tr><td><strong>SCO Population Coverage<\/strong><\/td><td>~\u202f3\u202fbillion people across Eurasia; metabolic disease prevalence rising with urbanization and dietary changes<\/td><\/tr><tr><td><strong>China Medical Technology Export<\/strong><\/td><td>Center provides channel for domestic medtech, pharma, and digital health companies to access SCO markets<\/td><\/tr><tr><td><strong>Ruijin Hospital Reputation<\/strong><\/td><td>Top\u2011tier academic medical center with established international partnerships; credible platform for regional collaboration<\/td><\/tr><tr><td><strong>Belt and Road Synergy<\/strong><\/td><td>Aligns with broader Chinese infrastructure and trade initiatives; health cooperation as pillar of economic integration<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding center operationalization, partnership development, and regional health outcomes. Actual results may differ due to risks including geopolitical tensions, funding sustainability, and cross\u2011border regulatory complexity.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The China\u2011Shanghai Cooperation Organization (SCO) Metabolic Disease Cooperation Center was officially established at Ruijin Hospital,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":58519,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[4445],"class_list":["post-58518","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-metabolic-disease"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The China\u2011Shanghai Cooperation Organization (SCO) Metabolic Disease Cooperation Center was officially established at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. This marks the first national\u2011level SCO specialized cooperation platform hosted by Shanghai, representing a significant advancement in China&#039;s efforts to drive global prevention and control of metabolic diseases through regional multilateral collaboration.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=58518\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai\" \/>\n<meta property=\"og:description\" content=\"The China\u2011Shanghai Cooperation Organization (SCO) Metabolic Disease Cooperation Center was officially established at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. This marks the first national\u2011level SCO specialized cooperation platform hosted by Shanghai, representing a significant advancement in China&#039;s efforts to drive global prevention and control of metabolic diseases through regional multilateral collaboration.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=58518\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-02T05:12:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-02T05:12:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0201.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58518#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58518\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai\",\"datePublished\":\"2026-03-02T05:12:46+00:00\",\"dateModified\":\"2026-03-02T05:12:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58518\"},\"wordCount\":446,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58518#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/0201.webp\",\"keywords\":[\"Metabolic disease\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=58518#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58518\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=58518\",\"name\":\"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58518#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58518#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/0201.webp\",\"datePublished\":\"2026-03-02T05:12:46+00:00\",\"dateModified\":\"2026-03-02T05:12:47+00:00\",\"description\":\"The China\u2011Shanghai Cooperation Organization (SCO) Metabolic Disease Cooperation Center was officially established at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. This marks the first national\u2011level SCO specialized cooperation platform hosted by Shanghai, representing a significant advancement in China's efforts to drive global prevention and control of metabolic diseases through regional multilateral collaboration.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58518#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=58518\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58518#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/0201.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/0201.webp\",\"width\":1080,\"height\":608,\"caption\":\"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58518#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai - Insight, China&#039;s Pharmaceutical Industry","description":"The China\u2011Shanghai Cooperation Organization (SCO) Metabolic Disease Cooperation Center was officially established at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. This marks the first national\u2011level SCO specialized cooperation platform hosted by Shanghai, representing a significant advancement in China's efforts to drive global prevention and control of metabolic diseases through regional multilateral collaboration.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=58518","og_locale":"en_US","og_type":"article","og_title":"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai","og_description":"The China\u2011Shanghai Cooperation Organization (SCO) Metabolic Disease Cooperation Center was officially established at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. This marks the first national\u2011level SCO specialized cooperation platform hosted by Shanghai, representing a significant advancement in China's efforts to drive global prevention and control of metabolic diseases through regional multilateral collaboration.","og_url":"https:\/\/flcube.com\/?p=58518","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-03-02T05:12:46+00:00","article_modified_time":"2026-03-02T05:12:47+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0201.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=58518#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=58518"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai","datePublished":"2026-03-02T05:12:46+00:00","dateModified":"2026-03-02T05:12:47+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=58518"},"wordCount":446,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=58518#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0201.webp","keywords":["Metabolic disease"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=58518#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=58518","url":"https:\/\/flcube.com\/?p=58518","name":"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=58518#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=58518#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0201.webp","datePublished":"2026-03-02T05:12:46+00:00","dateModified":"2026-03-02T05:12:47+00:00","description":"The China\u2011Shanghai Cooperation Organization (SCO) Metabolic Disease Cooperation Center was officially established at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. This marks the first national\u2011level SCO specialized cooperation platform hosted by Shanghai, representing a significant advancement in China's efforts to drive global prevention and control of metabolic diseases through regional multilateral collaboration.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=58518#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=58518"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=58518#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0201.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0201.webp","width":1080,"height":608,"caption":"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=58518#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China\u2011SCO Metabolic Disease Cooperation Center Established at Ruijin Hospital \u2013 First National\u2011Level SCO Platform in Shanghai"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0201.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=58518"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58518\/revisions"}],"predecessor-version":[{"id":58520,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58518\/revisions\/58520"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/58519"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=58518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=58518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=58518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}